Summary

The global Capsule Endoscopy Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Capsule endoscope is an ingestible capsule which measures pH, temperature, and pressure as it passes to the gastrointestinal tract to access GI reaction; they also capture and deliver images of GI tract to the receiver or data belt, which physicians can view on their phone or computer for examination purpose.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Capsule Endoscopy Diagnostics market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
CapsoVision, Inc.
Check-Cap Ltd.
Medtronic
IntroMedic Co., Ltd.
Olympus Corporation
Segment by Type
Polyps Detection
Crohn's Disease Diagnosis
Ulcers Monitoring
Celiac Detection
Tumors Of Small Intestine
Occult Gastrointestinal Bleeding
Diverticulosis Detection
Segment by Application
Hospitals
Ambulatory Centers
Private Clinics
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Capsule Endoscopy Diagnostics study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; top-tier players 2024 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Capsule Endoscopy Diagnostics: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Capsule Endoscopy Diagnostics Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Polyps Detection
1.2.3 Crohn's Disease Diagnosis
1.2.4 Ulcers Monitoring
1.2.5 Celiac Detection
1.2.6 Tumors Of Small Intestine
1.2.7 Occult Gastrointestinal Bleeding
1.2.8 Diverticulosis Detection
1.3 Market Segmentation by Application
1.3.1 Global Capsule Endoscopy Diagnostics Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Ambulatory Centers
1.3.4 Private Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Capsule Endoscopy Diagnostics Revenue Estimates and Forecasts 2020-2031
2.2 Global Capsule Endoscopy Diagnostics Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Capsule Endoscopy Diagnostics Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Capsule Endoscopy Diagnostics Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Polyps Detection Market Size by Players
3.3.2 Crohn's Disease Diagnosis Market Size by Players
3.3.3 Ulcers Monitoring Market Size by Players
3.3.4 Celiac Detection Market Size by Players
3.3.5 Tumors Of Small Intestine Market Size by Players
3.3.6 Occult Gastrointestinal Bleeding Market Size by Players
3.3.7 Diverticulosis Detection Market Size by Players
3.4 Global Capsule Endoscopy Diagnostics Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Capsule Endoscopy Diagnostics Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Capsule Endoscopy Diagnostics Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Capsule Endoscopy Diagnostics Market Size by Type (2020-2031)
6.4 North America Capsule Endoscopy Diagnostics Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Capsule Endoscopy Diagnostics Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Capsule Endoscopy Diagnostics Market Size by Type (2020-2031)
7.4 Europe Capsule Endoscopy Diagnostics Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Capsule Endoscopy Diagnostics Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Capsule Endoscopy Diagnostics Market Size by Type (2020-2031)
8.4 Asia-Pacific Capsule Endoscopy Diagnostics Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Capsule Endoscopy Diagnostics Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Capsule Endoscopy Diagnostics Market Size by Type (2020-2031)
9.4 Central and South America Capsule Endoscopy Diagnostics Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Capsule Endoscopy Diagnostics Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Capsule Endoscopy Diagnostics Market Size by Type (2020-2031)
10.4 Middle East and Africa Capsule Endoscopy Diagnostics Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Capsule Endoscopy Diagnostics Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 CapsoVision, Inc.
11.1.1 CapsoVision, Inc. Corporation Information
11.1.2 CapsoVision, Inc. Business Overview
11.1.3 CapsoVision, Inc. Capsule Endoscopy Diagnostics Product Features and Attributes
11.1.4 CapsoVision, Inc. Capsule Endoscopy Diagnostics Revenue and Gross Margin (2020-2025)
11.1.5 CapsoVision, Inc. Capsule Endoscopy Diagnostics Revenue by Product in 2024
11.1.6 CapsoVision, Inc. Capsule Endoscopy Diagnostics Revenue by Application in 2024
11.1.7 CapsoVision, Inc. Capsule Endoscopy Diagnostics Revenue by Geographic Area in 2024
11.1.8 CapsoVision, Inc. Capsule Endoscopy Diagnostics SWOT Analysis
11.1.9 CapsoVision, Inc. Recent Developments
11.2 Check-Cap Ltd.
11.2.1 Check-Cap Ltd. Corporation Information
11.2.2 Check-Cap Ltd. Business Overview
11.2.3 Check-Cap Ltd. Capsule Endoscopy Diagnostics Product Features and Attributes
11.2.4 Check-Cap Ltd. Capsule Endoscopy Diagnostics Revenue and Gross Margin (2020-2025)
11.2.5 Check-Cap Ltd. Capsule Endoscopy Diagnostics Revenue by Product in 2024
11.2.6 Check-Cap Ltd. Capsule Endoscopy Diagnostics Revenue by Application in 2024
11.2.7 Check-Cap Ltd. Capsule Endoscopy Diagnostics Revenue by Geographic Area in 2024
11.2.8 Check-Cap Ltd. Capsule Endoscopy Diagnostics SWOT Analysis
11.2.9 Check-Cap Ltd. Recent Developments
11.3 Medtronic
11.3.1 Medtronic Corporation Information
11.3.2 Medtronic Business Overview
11.3.3 Medtronic Capsule Endoscopy Diagnostics Product Features and Attributes
11.3.4 Medtronic Capsule Endoscopy Diagnostics Revenue and Gross Margin (2020-2025)
11.3.5 Medtronic Capsule Endoscopy Diagnostics Revenue by Product in 2024
11.3.6 Medtronic Capsule Endoscopy Diagnostics Revenue by Application in 2024
11.3.7 Medtronic Capsule Endoscopy Diagnostics Revenue by Geographic Area in 2024
11.3.8 Medtronic Capsule Endoscopy Diagnostics SWOT Analysis
11.3.9 Medtronic Recent Developments
11.4 IntroMedic Co., Ltd.
11.4.1 IntroMedic Co., Ltd. Corporation Information
11.4.2 IntroMedic Co., Ltd. Business Overview
11.4.3 IntroMedic Co., Ltd. Capsule Endoscopy Diagnostics Product Features and Attributes
11.4.4 IntroMedic Co., Ltd. Capsule Endoscopy Diagnostics Revenue and Gross Margin (2020-2025)
11.4.5 IntroMedic Co., Ltd. Capsule Endoscopy Diagnostics Revenue by Product in 2024
11.4.6 IntroMedic Co., Ltd. Capsule Endoscopy Diagnostics Revenue by Application in 2024
11.4.7 IntroMedic Co., Ltd. Capsule Endoscopy Diagnostics Revenue by Geographic Area in 2024
11.4.8 IntroMedic Co., Ltd. Capsule Endoscopy Diagnostics SWOT Analysis
11.4.9 IntroMedic Co., Ltd. Recent Developments
11.5 Olympus Corporation
11.5.1 Olympus Corporation Corporation Information
11.5.2 Olympus Corporation Business Overview
11.5.3 Olympus Corporation Capsule Endoscopy Diagnostics Product Features and Attributes
11.5.4 Olympus Corporation Capsule Endoscopy Diagnostics Revenue and Gross Margin (2020-2025)
11.5.5 Olympus Corporation Capsule Endoscopy Diagnostics Revenue by Product in 2024
11.5.6 Olympus Corporation Capsule Endoscopy Diagnostics Revenue by Application in 2024
11.5.7 Olympus Corporation Capsule Endoscopy Diagnostics Revenue by Geographic Area in 2024
11.5.8 Olympus Corporation Capsule Endoscopy Diagnostics SWOT Analysis
11.5.9 Olympus Corporation Recent Developments
12 Capsule Endoscopy DiagnosticsIndustry Chain Analysis
12.1 Capsule Endoscopy Diagnostics Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Capsule Endoscopy Diagnostics Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Capsule Endoscopy Diagnostics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details